Enlivex Therapeutics Ltd. (ENLV) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Total Current Assets | 1.74B | 19.5M | 21.32M | 22.65M | 25.99M | 27.11M | 28.57M | 28.38M | 33.76M | 31.84M | 30.79M | 37.58M | 52.33M | 59.23M | 65.05M | 79.3M | 86.44M | 90.28M | 92.83M | 93.78M |
| Cash & Short-Term Investments | 5.87M | 18.32M | 19.51M | 20.55M | 23.61M | 24.5M | 25.94M | 23.55M | 27.43M | 30.5M | 28.9M | 35.98M | 48.12M | 38.55M | 62.48M | 78M | 84.13M | 87.63M | 90.6M | 91.67M |
| Cash Only | 2.01M | 4.2M | 1.89M | 2.05M | 3.3M | 2.77M | 3.75M | 2.03M | 926K | 1.97M | 3.46M | 13.14M | 47.82M | 38.55M | 20.15M | 67.67M | 11.2M | 22.15M | 12.61M | 4.09M |
| Short-Term Investments | 3.86M | 14.12M | 17.61M | 18.5M | 20.2M | 21.73M | 22.2M | 21.52M | 26.51M | 28.53M | 25.44M | 22.84M | 299K | 0 | 42.33M | 10.34M | 72.93M | 65.48M | 77.99M | 87.58M |
| Accounts Receivable | 235K | 567K | 890K | 1.13M | 1.3M | 1.29M | 1.15M | 3.81M | 229K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.09M | 0 | 0 | 885K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 113K | 113K | 0 | -229K | 0 | 0 | 0 | 1.18M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | 64.57 | 64.27 | - | - | - | - | - | 489.97 | - | - | - | - | - | - | - |
| Other Current Assets | 1.73B | 85K | 238K | 217K | 198K | 228K | 228K | 4.04M | 5.34M | 0 | 0 | 0 | 0 | 113K | 113K | 113K | 1.2M | 874K | 883K | 340K |
| Total Non-Current Assets | 583.82M | 1.44M | 1.27M | 1.39M | 1.69M | 2.69M | 3.33M | 2.67M | 3.07M | 15.1M | 22.24M | 22.44M | 15.31M | 13.18M | 12.29M | 9.32M | 8.7M | 7.89M | 2.36M | 2.19M |
| Property, Plant & Equipment | 938K | 1.08M | 923K | 1.07M | 1.15M | 1.77M | 2.03M | 2.24M | 2.58M | 14.3M | 14.31M | 14.79M | 14.9M | 12.76M | 11.89M | 8.87M | 8.22M | 7.57M | 2.27M | 2.1M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 582.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 374K | 359K | 351K | 319K | 531K | 826K | 1.21M | 319K | 308K | 284K | 7.45M | 7.55M | 307K | 283K | 286K | 312K | 3K | 307K | 88K | 86K |
| Other Non-Current Assets | 0 | 359K | 351K | 319K | 10K | 915K | 92K | 110K | 179K | 512K | 485K | 104K | 105K | 139K | 118K | 136K | 482K | 6K | 6K | 5K |
| Total Assets | 2.33B | 20.94M | 22.6M | 24.04M | 27.69M | 29.8M | 31.9M | 31.05M | 36.83M | 46.94M | 53.03M | 60.02M | 67.64M | 72.41M | 77.34M | 88.62M | 95.15M | 98.17M | 95.19M | 95.96M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 8304.66% | -29.73% | -29.16% | -22.59% | -24.83% | -36.52% | -39.84% | -48.27% | -45.55% | -35.18% | -31.44% | -32.27% | -28.91% | -26.23% | -18.75% | -7.65% | 135.75% | 194.16% | 168.61% | 154.87% |
| Total Current Liabilities | 9.02M | 3.03M | 3.33M | 3.14M | 3.8M | 2.79M | 2.84M | 3.61M | 6.06M | 4.34M | 4.99M | 5.45M | 6.61M | 4.53M | 4.21M | 5.74M | 4.72M | 4.73M | 4.58M | 4.91M |
| Accounts Payable | 3.81M | 375K | 542K | 533K | 811K | 92K | 303K | 643K | 827K | 794K | 1.55M | 1.48M | 1.95M | 1.06M | 667K | 1.36M | 878K | 1.06M | 558K | 347K |
| Days Payables Outstanding | 2.53K | 520.77 | 575.44 | 672 | 1.15K | 112.86 | 269.02 | 355.77 | 372.83 | 504.71 | 651.81 | 738.73 | 625.27 | 412.8 | 523.51 | 535.21 | 594.93 | 474.65 | 337.52 | 311.54 |
| Short-Term Debt | 0 | 0 | 264K | 239K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.89M | 602K | 1.2M | 1.17M | 1.55M | 301K | 291K | 351K | 1.23M | 372K | 1.07M | 1.35M | 1.3M | 113K | 113K | 113K | 1.59M | 792K | 793K | 1.15M |
| Current Ratio | 193.24x | 6.43x | 6.41x | 7.20x | 6.84x | 9.71x | 10.06x | 7.86x | 5.57x | 7.34x | 6.17x | 6.89x | 7.92x | 13.08x | 15.44x | 13.81x | 18.32x | 19.08x | 20.29x | 19.11x |
| Quick Ratio | 193.24x | 6.43x | 6.41x | 7.20x | 6.84x | 9.67x | 10.02x | 7.86x | 5.61x | 7.34x | 6.17x | 6.89x | 7.74x | 13.08x | 15.44x | 13.81x | 18.32x | 19.08x | 20.29x | 19.11x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 383.03M | 426K | 216K | 264K | 299K | 419K | 499K | 587K | 686K | 3.82M | 3.7M | 4M | 4.19M | 4.61M | 4.64M | 5.23M | 5.39M | 5.35M | 405K | 449K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.61M | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 383K | 426K | 216K | 264K | 299K | 419K | 499K | 587K | 686K | 3.82M | 3.7M | 4M | 4.19M | 4.61M | 4.64M | 5.23M | 5.39M | 5.35M | 405K | 449K |
| Deferred Tax Liabilities | 382.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.61M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 392.05M | 3.46M | 3.54M | 3.41M | 4.1M | 3.21M | 3.34M | 4.2M | 6.75M | 8.16M | 8.69M | 9.45M | 10.8M | 9.14M | 8.86M | 10.97M | 10.11M | 10.08M | 4.98M | 5.36M |
| Total Debt | 641K | 701K | 480K | 503K | 534K | 765K | 835K | 928K | 1.03M | 4.52M | 4.37M | 4.68M | 4.85M | 5.26M | 629K | 694K | 6.01M | 636K | 210K | 205K |
| Net Debt | -1.37M | -3.5M | -1.41M | -1.55M | -2.77M | -2.01M | -2.91M | -1.1M | 106K | 2.55M | 911K | -8.46M | -42.98M | -33.29M | -19.52M | -66.97M | -5.2M | -21.51M | -12.4M | -3.88M |
| Debt / Equity | 0.00x | 0.04x | 0.03x | 0.02x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.12x | 0.10x | 0.09x | 0.09x | 0.08x | 0.01x | 0.01x | 0.07x | 0.01x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -27.15x | - | - | - | - | -15.59x | - | -101.38x | -1.45x | -3.52x | - | - | - | - |
| Total Equity | 1.93B | 17.48M | 19.05M | 20.63M | 23.59M | 26.59M | 28.56M | 26.85M | 30.08M | 38.78M | 44.34M | 50.57M | 56.84M | 63.27M | 68.49M | 77.65M | 85.04M | 88.08M | 90.21M | 90.61M |
| Equity Growth % | 8102.76% | -34.25% | -33.29% | -23.18% | -21.59% | -31.44% | -35.58% | -46.91% | -47.07% | -38.71% | -35.26% | -34.87% | -33.16% | -28.17% | -24.08% | -14.3% | 139.63% | 209.07% | 198.77% | 182.62% |
| Book Value per Share | 40.15 | 0.73 | 0.80 | 0.94 | 1.08 | 1.25 | 1.46 | 1.43 | 1.62 | 2.09 | 2.39 | 2.73 | 3.09 | 3.44 | 3.73 | 4.23 | 4.64 | 4.81 | 4.93 | 5.50 |
| Total Shareholders' Equity | 1.93B | 17.48M | 19.05M | 20.63M | 23.59M | 26.59M | 28.56M | 26.85M | 30.08M | 38.78M | 44.34M | 50.57M | 56.84M | 63.27M | 68.49M | 77.65M | 85.04M | 88.08M | 90.21M | 90.61M |
| Common Stock | 28.73M | 2.76M | 2.71M | 2.71M | 2.69M | 2.5M | 2.38M | 2.16M | 2.14M | 2.14M | 2.14M | 2.13M | 2.12M | 2.12M | 2.11M | 2.11M | 2.11M | 2.11M | 2.1M | 2.1M |
| Retained Earnings | 1.11B | -134.63M | -132.43M | -130.56M | -127.11M | -121.93M | -119.33M | -116.23M | -112.09M | -103M | -97.03M | -90.24M | -83.03M | -75.84M | -70.1M | -60.19M | -51.97M | -47.23M | -43.8M | -40.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 244K | -1.81M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |